Mechanisms of Cognitive Control Impairment in ME/CFS and PASC-ME/CFS

Document text

Principal Investigator: H Hamdi Eryilmaz
Organization: MASSACHUSETTS GENERAL HOSPITAL
Fiscal Year: 2024
Award: $463,290
Funding agency: National Institute of Neurological Disorders and Stroke

ABSTRACT
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a symptom-based diagnosis characterized
by severe debilitating fatigue, cognitive dysfunction, and widespread pain. Most cases of ME/CFS begin with a
viral infection or involve multiple exposures to pathogens over time. Soon after the onset of the COVID-19
pandemic, a significant portion of patients infected with SARS-CoV-2 developed chronic symptoms that
overlap greatly with those of ME/CFS. Among the post-acute sequelae of COVID-19 (PASC), “brain fog”
symptoms have been widely reported including in patients with mild initiating infection. Many PASC patients
meet the diagnostic criteria for ME/CFS after 6 months of ongoing symptoms (referred to herein as PASCME/CFS). Given the growing number of SARS-CoV-2 infections, the disease burden on individuals with
ME/CFS and PASC-ME/CFS, and the challenges associated with these conditions such as rehabilitation and
workforce disruptions, elucidating the mechanisms of cognitive deficits in ME/CFS and PASC-ME/CFS is of
clear 

Terms: <Acceleration><American><Anterior><Attention><Autonomic Dysfunction><Brain><Brain Nervous System><Brain imaging><COVID crisis><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infected patient><COVID-19 infection><COVID-19 pandemic><COVID-19 patient><COVID-19 period><COVID-19 positive patient><COVID-19 public health crisis><COVID-19 virus infection><COVID-19 years><COVID19 infection><COVID19 patient><COVID19 positive patient><CV-19><Chronic Fatigue Disorder><Chronic Fatigue Syndrome><Chronic Fatigue and Immune Dysfunction Syndrome><Chronic Infectious Mononucleosis-Like Syndrome><Clinical Trials><Cognition><Cognitive Disturbance><Cognitive Impairment><Cognitive Manifestations><Cognitive Symptoms><Cognitive decline><Cognitive deficits><Cognitive function abnormal><Conflict><Conflict (Psychology)><Coronavirus Infectious Disease 2019><Data><Diagnosis><Disturbance in cognition><Dorsal><Dysfunction><EEG><Electroencephalogram><Electroencephalography><Electrophysiology><Electrophysiology (science)><Encephalon><Exertion><Exhibits><Exposure to><Fatigue><Functional MRI><Functional Magnetic Resonance Imaging><Functional disorder><Future><Goals><IQ Deficit><Immediate Memory><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Impaired cognition><Impairment><Individual><Infection><Inflammation><Lack of Energy><Long COVID><Long COVID-19><Long coronavirus disease><Long coronavirus disease 2019><ME/CFS><Malaise><Measures><Medical Rehabilitation><Memory><Methods><Myalgic Encephalomyelitis><Neurobehavioral Manifestations><Neurobehavioral Signs and Symptoms><Neurocognitive Deficit><Neurophysiology / Electrophysiology><PASC><Pain><Painful><Patients><Pattern><Performance><Peripheral><Physiopathology><Pilot Projects><Post Acute Sequelae of COVID19><Post Acute Sequelae of SARS-CoV-2><Post Acute Sequelae of SARS-CoV2><Post Acute Sequelae of severe acute respiratory syndrome coronavirus 2><Post-Acute Sequelae of SARS-CoV-2 Infection><Postviral Fatigue Syndrome><Psychoses><Qualifying><Reaction Time><Rehabilitation><Rehabilitation therapy><Reporting><Research><Response RT><Response Time><Royal Free Disease><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV2 infection><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Short-Term Memory><Shortterm Memory><Source><Symptoms><Time><Viral Diseases><Virus Diseases><Work><adverse sequelae of COVID><adverse sequelae of COVID-19><adverse sequelae of coronavirus disease><adverse sequelae of coronavirus disease 2019><biomarker identification><brain fog><brain visualization><burden of disease><burden of illness><chronic COVID><chronic COVID-19><chronic COVID-19 sequelae><chronic novel coronavirus disease 2019><chronic symptom><cingulate cortex><cognitive control><cognitive defects><cognitive dysfunction><cognitive loss><compare to control><comparison control><computer based prediction><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 patient><coronavirus infectious disease-19><coronavirus patient><cost><cytokine><develop therapy><diagnostic criteria><disease burden><effective intervention><electrophysiological><experience><fMRI><identification of biomarkers><identification of new biomarkers><improved><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><inflammation marker><inflammatory marker><intelligence quotient deficit><intervention development><long haul COVID><long haul COVID-19><long haul coronavirus disease><long haul coronavirus disease 2019><long haul sequelae of COVID-19><long haul sequelae of coronavirus disease 2019><long-hauler COVID><long-hauler COVID-19><long-hauler coronavirus disease 2019><long-hauler syndrome><long-term COVID><long-term COVID-19><long-term coronavirus disease><long-term coronavirus disease 2019><long-term sequelae of COVID-19><long-term sequelae of SARS-CoV-2><long-term sequelae of coronavirus disease 2019><long-term sequelae of severe acute respiratory syndrome coronavirus 2><longterm COVID><longterm COVID-19><longterm coronavirus disease><longterm coronavirus disease 2019><marker identification><multi-modality><multimodality><neural imaging><neural mechanism><neuro-imaging><neurobehavioral symptom><neurocognitive decline><neurocognitive impairment><neuroimaging><neurological imaging><neuromechanism><neurophysiological><neurophysiology><neuropsychiatric><neuropsychiatry><novel><pathogen><pathophysiology><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><persistent COVID-19><persistent symptom><pilot study><post COVID syndrome><post COVID-19 sequelae><post COVID-19 syndrome><post acute COVID syndrome><post acute COVID-19><post acute COVID-19 syndrome><post acute SARS-CoV-2><post acute coronavirus disease 2019><post acute coronavirus disease 2019 syndrome><post acute coronavirus disease syndrome><post acute sequelae following COVID-19><post acute severe acute respiratory syndrome coronavirus 2><post coronavirus disease 2019 syndrome><post coronavirus disease syndrome><post-acute phases of COVID-19><post-acute sequelae following SARS-CoV-2 infection><post-acute sequelae of COVID-19><post-acute sequelae of acute COVID infection><post-acute sequelae of coronavirus disease 2019><predictive modeling><prolonged COVID-19 symptoms><psychomotor reaction time><rehab therapy><rehabilitative><rehabilitative therapy><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><targeted biomarker><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><temporal measurement><temporal resolution><therapy development><time measurement><tool><treatment development><viral infection><virus infection><virus-induced disease><working memory>